To hear about similar clinical trials, please enter your email below
Trial Title:
First-in-human Navigation Endoscopic Ultrasound (EUS) System Clinical Study
NCT ID:
NCT05515705
Condition:
Pancreatic Disease
Conditions: Official terms:
Pancreatic Diseases
Conditions: Keywords:
Endoscopic ultrasound
EUS
Biliopancreatic
Pancreatic cancer
PDAC
EUS navigation
Education
Training
Learning curve
Quality indicators
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Other
Masking:
None (Open Label)
Intervention:
Intervention type:
Device
Intervention name:
EUS navigation system
Description:
Incorporation of the EUS navigation system to the EUS scope
Arm group label:
EUS-NS +
Arm group label:
EUS-NS -
Summary:
The implementation of Echo-endoscopy (or EUS for: Endoscopic UltraSound) is limited by
the difficulty of obtaining quality EUS procedures, since the accuracy of the method
relies on the endoscopist's abilities. Indeed, both cognitive and technical skills are
required for endoscopic manipulation and image interpretation, as well as a thorough
knowledge of intra-abdominal anatomy. The "EUS-GPS" system aims to assist the operator in
understanding the orientation and location of the probe tip within the patient. For that,
a Global Positioning System (GPS) for EUS procedures is intraoperatively provided, using
a 3D-based model based on recorded preoperative data.
In this clinical investigation, the EUS GPS system is intended to help EUS operators to
correctly navigate towards the pancreatic gland, perform a comprehensive assessment of
the area of interest, and aid in the detection and identification of lesions.
Detailed description:
Since its emergence in the 1980s, endoscopic ultrasound (EUS) is considered as one of the
most accurate tools for the evaluation of the pancreatic gland and other gastrointestinal
(GI) disorders. Despite its utility, the practice of EUS is still far from being part of
every endoscopy suite due to its high set-up cost and the relative scarcity of
credentialed experts. EUS implementation worldwide has been limited by the difficulty of
achieving quality EUS procedures, since the accuracy of the method relies on the
endoscopist's abilities. Both cognitive and technical competencies are required for
endoscopic manipulation and image interpretation, as well as extensive knowledge of
intraabdominal anatomy.
The aim of the APEUS (Augmented Pancreatic Endoscopic UltraSound) project is to overcome
these two main difficulties by providing a Global Positioning System (GPS)-like
intraoperative navigation for EUS procedures, using a 3D-based model on registered
preoperative data. The hypothesis is that, thanks to this tool, the procedures time would
be shortened, and the pancreas and its lesions would be completely imaged. This would
reduce the demand for experts guiding trainees and shorten the EUS learning curve.
This first-in-human clinical study will enable the assessment of safety and qualitative
performance of the EUS-GPS solution. The primary objective is to evaluate the EUS
navigation system's procedure duration compared to standard procedure times (patient
group with the EUS-GPS system vs control group without).
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Man or woman over the age of 18 years old
- Patient having a EUS procedure for pancreas study planned within the frame of his or
her clinical care.
- Patient whom pre-operative imaging indicates one lesion with a good definition on
the triphasic CT scan done within the 60 days prior to the EUS.
- Patient able to receive and understand information related to the study and give his
or her written consent
- Patient affiliated to the French social security system
Exclusion Criteria:
- Patient unable to give informed consent
- Patient with altered anatomy of the upper digestive tract due to previous surgery
- Patient with known abnormal anatomy of the upper digestive tract
- Patient wearing a metal implantable device (pacemaker, etc.)
- Patient presenting, according to the investigator's judgment, a disease which may
prevent participation in the procedures provided for by the study
- Patient with an ASA (American Society of Anesthesiologists) score >2
- Patient with multiple pancreatic lesions.
- Patient unable to tolerate general anaesthesia
- Patient with a body mass index (BMI) < 23 and > 40
- Patient with weight variations of >10% between the date on which the CT scan was
performed and the date of the procedure.
- Pregnant or lactating patient
- Patient in exclusion period (determined by a previous or a current study)
- Patient under guardianship or trusteeship
- Patient under the protection of justice of deprives of liberty
- Patient in situation of emergency
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Pôle Hépato-Digestif, NHC
Address:
City:
Strasbourg
Zip:
67000
Country:
France
Status:
Recruiting
Contact:
Last name:
Leonardo SOSA VALENCIA, MD
Email:
leonardo.sosa-valencia@ihu-strasbourg.eu
Start date:
January 10, 2023
Completion date:
February 2025
Lead sponsor:
Agency:
IHU Strasbourg
Agency class:
Other
Source:
IHU Strasbourg
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05515705